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The recent development of arterivirus full-length cDNA clones makes possible the construction of chimeric arteriviruses
for fundamental and applied studies. Using an equine arteritis virus (EAV) infectious cDNA clone, we have engineered
chimeras in which the ectodomains of the two major envelope proteins, the glycoprotein GP5 and the membrane protein M,
were replaced by sequences from envelope proteins of related and unrelated RNA viruses. Using immunofluorescence
microscopy, we monitored the transport of the hybrid GP5 and M proteins to the Golgi complex, which depends on their
heterodimerization and is a prerequisite for virus assembly. The only viable chimeras were those containing the GP5
ectodomain from the porcine (PRRSV) or mouse (LDV) arteriviruses, which are both considerably smaller than the corre-
sponding sequence of EAV. Although the two viable GP5 chimeras were attenuated, they were still able to infect baby hamster
kidney (BHK-21) and rabbit kidney (RK-13) cells. These cells can be infected by EAV, but not by either PRRSV or LDV. This
implies that the ectodomain of the major glycoprotein GP5, which has been postulated to be involved in receptor recognition,
is not the main determinant of EAV tropism in cell culture. © 2001 Academic PressKey Words: equine arteritis virus; nidovirus; arterivirus; chimeric viruses; tropism; structural proteins; glycoprotein;
membrane proteins; infectious cDNA clone; receptor; heterodimerization.INTRODUCTION
Arteriviruses are enveloped, positive-stranded RNA vi-
ruses with a diameter of 40–60 nm (for reviews, see
Snijder and Meulenberg, 1998; Brinton, 1999). In addition
to the family prototype equine arteritis virus (EAV) (Doll et
al., 1957), the Arteriviridae family contains the lactate
dehydrogenase-elevating virus (LDV) of mice, porcine
reproductive and respiratory syndrome virus (PRRSV),
and simian hemorrhagic fever virus (SHFV). The conse-
quences of arterivirus infection in susceptible animals
can range from an asymptomatic, persistent, or acute
infection to abortion or lethal hemorrhagic fever.
Despite a considerable difference in genome size, the
nonstructural proteins and genome expression strategy
of arteriviruses are related to those of the Coronaviridae
(Lai and Cavanagh, 1997; de Vries et al., 1997; Snijder
and Meulenberg, 1998), which was the basis for the joint
classification of both families in the Order Nidovirales.
However, the sizes and architecture of arteri- and coro-
navirus particles are strikingly different. Arteriviruses
possess a set of six or seven structural proteins, a
number that is unusually large compared to other posi-
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Virology, Center of Infectious Diseases,
eiden University Medical Center, LUMC P4-26, PO Box 9600, 2300 RC
eiden, The Netherlands. Fax: **31 71 5266761. E-mail:
.J.Snijder@LUMC.nl.
283tive-stranded RNA viruses, including coronaviruses. The
arterivirus nucleocapsid is composed of the 12.7- to
15.7-kb RNA genome and a small nucleocapsid (N) pro-
tein (110–128 aa). The envelope that surrounds the nu-
cleocapsid contains five or six envelope proteins. Two of
these are major structural components, the nonglycosy-
lated integral membrane protein M, and the “major” gly-
coprotein (de Vries et al., 1992; Faaberg and Plagemann,
1995; Meulenberg et al., 1995). Different numbers of
additional “minor” envelope proteins have been identified
for different arteriviruses (see Snijder and Meulenberg,
1998; Dea et al., 2000). The nomenclature of arterivirus
envelope glycoproteins (GPs) has not yet been standard-
ized. For example, the major glycoprotein has been des-
ignated GL, VP-3P, GP5, and p54 in the case of EAV, LDV,
PRRSV, and SHFV, respectively. In this paper, we will
refer to the glycoproteins as GPx, where x indicates the
number of the open reading frame (ORF) in the genome
from which the protein is expressed (Fig. 1A).
The three major structural proteins GP5, M, and N are
encoded in this order by the three most 39 ORFs of the
arterivirus genome (Fig. 1A). The M protein (162–173 aa)
is the most conserved structural protein of arteriviruses.
It resembles the coronavirus M protein in that its N-
terminal half presumably spans the membrane three
times (de Vries et al., 1992; Faaberg and Plagemann,
1995), leaving only a short stretch of 10–18 residues
exposed at the virion surface (Fig. 1C). The M protein
forms a disulfide-linked heterodimer with the major gly-
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284 DOBBE ET AL.coprotein GP5 (de Vries et al., 1995; Faaberg et al., 1995).
espite considerable differences in primary structure,
he major glycoproteins of arteriviruses (GP5 and its
SHFV equivalent GP7; 199–278 aa) share common struc-
tural features (Fig. 1B). They contain an N-terminal signal
sequence that is cleaved from a relatively small ectodo-
main. In the case of LDV and PRRSV, the ectodomain is
only about 30 residues long and contains one to three
N-linked glycans (Faaberg and Plagemann, 1995; Meu-
lenberg et al., 1993; Murtaugh et al., 1995). The putative
ectodomain of EAV GP5 is 95 residues long and usually
ossesses a single N-linked polylactosamine side chain
de Vries et al., 1992). In the case of LDV GP5, glycosyl-
tion occurs by the addition of variable numbers of lac-
osamine repeats (Li et al., 1998). Non-neuropathogenic
nd neuropathogenic strains typically contain three and
ne polylactosaminoglycan chain(s), respectively, a
roperty that has been related to the efficiency of neu-
FIG. 1. (A) Organization of the 39-terminal part of the EAV genome (d
and the 39 poly(A) tail of the genome are shown. Below, the ORF 4 to 6 re
described in this study (pA45, pA56, and pA456). In these constructs th
had been removed (de Vries et al., 2000). The sequences encoding t
restriction sites used to engineer the chimeric GP5 and M proteins are
nd ectodomain sequence of EAV GP5. The hydrophobicity plot was ge
f 11; above the axis is hydrophobic. In the GP5 ectodomain sequence
indicated, and the single N-glycosylation site is boxed. The EcoRI restr
foreign ectodomains to the transmembrane region of EAV GP5. (C) Hy
further details. The XbaI restriction site (encoding the amino acids Leu
proteins to the transmembrane region of the EAV M protein.ralization and the establishment of a persistent infection
Chen et al., 1997; Li et al., 1998). The internal hydropho-
m
Pic region of GP5 probably spans the membrane three
imes and is followed by a cytoplasmic domain of 50–72
mino acids. Arteriviruses acquire their envelope by bud-
ing into the lumen of smooth membranes, probably
ncluding those of the Golgi complex. The specific roles
f the various envelope proteins in virus assembly and
nfectivity have not yet been established. However, by
utagenesis of an EAV infectious cDNA clone (van
inten et al., 1997), it was recently shown that the pro-
eins encoded by all 7 genes in the genomic 39 end of
AV (ORFs 2a to 7) are required for the production of
nfectious progeny virus (Molenkamp et al., 2000).
Macrophages appear to be the primary target cell for
ll arteriviruses (Plagemann, 1996). With the exception of
AV, arteriviruses have a very restricted tropism in cell
ulture (reviewed in Plagemann and Moennig, 1992, and
nijder and Meulenberg, 1998). LDV only replicates in
rimary mouse macrophages. In addition to primary
n et al., 1991). The seven ORFs located between the replicase ORF1b
depicted for the three constructs that formed the basis for the chimeras
lap between ORFs 4 and 5 and/or the overlap between ORFs 5 and 6
domains of GP5 and the M protein are depicted in gray. The unique
ted (see Materials and Methods and Table 1). (B) Hydrophobicity plot
d using the method of Kyte and Doolittle (1982) and a moving window
terminal signal sequence is underlined, the five cysteine residues are
ite (encoding the amino acids Glu-115 and Phe-116) was used to fuse
bicity plot and ectodomain sequence of the EAV M protein. See B for
Asp-18) was used to fuse the ectodomains of the LDV and PRRSV Men Boo
gion is
e over
he ecto
indica
nerate
the N-
iction s
drophoacrophages from their respective hosts, SHFV and
RRSV also replicate in African green monkey kidney
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285CONSTRUCTION OF CHIMERIC ARTERIVIRUSEScell lines (MA-104 and derivatives thereof). Remarkably,
EAV replicates efficiently in primary cultures of horse
macrophages and kidney cells, as well as in a variety of
kidney cell lines such as baby hamster kidney (BHK-21),
rabbit kidney (RK-13), and African green monkey kidney.
Upon transfection of genomic RNA, arteriviruses can
replicate in several cell lines that are not susceptible to
infection with virus particles (Inada et al., 1993; Meulen-
berg et al., 1998). These data suggest that cell tropism is,
mong other things, determined by the presence of an as
et unidentified receptor on the cell surface, which prob-
bly is the starting point of arterivirus entry by receptor-
ediated endocytosis (Kreutz and Ackermann, 1996).
By analogy with many other animal RNA viruses and in
iew of its recognition by neutralizing antibodies, it has
een speculated that the ectodomain of the arterivirus
ajor glycoprotein is involved in receptor recognition.
owever, direct experimental evidence for this assump-
ion has not been obtained. The recent development of
nfectious cDNA clones for arteriviruses (van Dinten et
al., 1997; Meulenberg et al., 1998; de Vries et al., 2000)
as now opened the possibility of modifying the proper-
ies of arterivirus structural proteins by reverse genetics.
n this paper, we describe the generation of the first
himeric arteriviruses in which envelope protein se-
uences from other arteriviruses have been introduced.
e have replaced the EAV GP5 ectodomain with the
orresponding sequence of the major glycoprotein of the
hree other arteriviruses and with the unrelated ectodo-
ains of glycoproteins from vesicular stomatitis virus
VSV) and Sindbis virus (SinV). The chimeric viruses
ontaining the GP5 ectodomains of LDV and PRRSV were
iable. Remarkably, both these chimeras retained their
nfectivity for BHK-21 cells, which can be infected with
AV, but not with LDV or PRRSV. This suggests that the
P5 ectodomain is not the main determinant of EAV
tropism. Constructs containing chimeric PRRSV/EAV or
LDV/EAV M proteins, or a combination of chimeric GP5
and M proteins, did not produce significant amounts of
infectious progeny. Our data indicated that the GP5 and
M proteins of these and other nonviable chimeras were
retained in the ER, an observation that underlines the
importance of the formation and transport of the GP5–M
eterodimer for arterivirus assembly.
RESULTS
isualization of heterodimerization and transport of
he EAV GP5–M heterodimer
Biochemical studies by de Vries et al. (1995) have
reviously established that a disulfide-linked het-
rodimer is formed between the EAV GP5 and M proteins
in infected cells. Heterodimerization coincides with
transport of the two proteins to the Golgi complex, as
evidenced by the endoglycosidase H resistance ac-
quired by the N-linked oligosaccharide of GP5. An inter- vesting observation of de Vries et al. concerned the dif-
ferent kinetics with which the two partners were re-
cruited into the GP5–M heterodimer. Pulse–chase
experiments showed that dimerization and transport
were much more efficient for GP5 than for the M protein.
This suggested the presence of an excess of M protein
in the ER, where heterodimerization is assumed to occur.
The most obvious explanation for this phenomenon is
the approximately 1:5 ratio between subgenomic mRNAs
5 and 6 of EAV, which encode GP5 and the M protein,
respectively.
To monitor the heterodimerization and transport of the
EAV GP5 and M proteins in a sensitive and rapid manner,
e have now developed a double indirect immunofluo-
escence assay (IFA) for the two proteins that relies on
he use of an anti-GP5 mouse monoclonal antibody
(MAb) and an M-protein-specific rabbit antiserum that
was raised using a C-terminal synthetic peptide. In time
course experiments (Fig. 2C), the expression of EAV
structural proteins in infected cells could first be de-
tected around 6 h pi. Both at this time point and later in
infection, GP5 localized to the Golgi complex and was not
etected in the ER. The Golgi localization of GP5 was
orroborated by performing a double labeling with an
ntiserum recognizing the medial Golgi marker manno-
idase II (Fig. 2A). In contrast to our findings for GP5, we
observed significant differences between the staining for
the M protein at early and late(r) time points (Fig. 2C). At
the onset of its synthesis (around 6 h pi.), the M protein
also localized mainly to the Golgi complex and its stain-
ing overlapped almost completely with that of GP5. Ap-
arently, the excess of M protein was not yet present at
his stage, resulting in efficient heterodimerization and
apid transport of the M protein. At 8 h pi, the situation in
ost cells had changed dramatically and the bulk of the
protein was present in the ER (Fig. 2C), as confirmed
y a double labeling (Fig. 2B) with a monoclonal antibody
gainst protein disulfide isomerase, a resident protein of
he ER (Vaux et al., 1990).
We have recently generated EAV knockout mutants in
which the expression of either GP5 or the M protein was
inactivated (Molenkamp et al., 2000). IFAs on cells trans-
fected with these mutants have revealed that both GP5
and the M protein were retained in the ER when the other
protein is not expressed. These observations again con-
firmed that GP5–M heterodimerization is essential for
ransport of either protein to the Golgi complex. They
lso confirmed that the double IFA described above is a
onvenient tool for monitoring the expression and trans-
ort of the chimeric GP5 and M proteins used in this
tudy.
eneration of chimeric virusesThe genetic information in the 39 end of the arteri-
irus genome is organized in an extremely efficient
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computer-generated overlay (yellow) of the GP5 and mannosidase II
images. The cell in the lower left corner of the image was not infected
286 DOBBE ET AL.manner (Snijder and Meulenberg, 1998). As a rule, the
structural protein genes in the 39 end of the genome
overlap with both adjacent genes over distances that
vary from a few to several hundred nucleotides (Fig.
1A). Obviously, these gene overlaps hamper the ge-
netic engineering of individual arterivirus genes in the
context of an infectious cDNA clone. However, de
Vries et al. (2000) recently described mutant EAV full-
length cDNA clones in which the overlaps between
EAV ORFs 4 and 5 and/or EAV ORFs 5 and 6 were
removed by the insertion of small additional se-
quences (24 and 17 nt, respectively) that contained a
termination codon for the upstream gene, a unique
AflII restriction site, and a translation initiation codon
for the downstream gene. These insertions resulted in
the functional separation of the overlapping ORFs,
were found not to significantly impair virus replication
or infectivity, and were stable upon repeated virus
passaging (de Vries et al., 2000).
On the basis of these observations, and using the
constructs described above, we have now engineered
chimeric EAV constructs in which the ectodomains of
GP5 and/or the M protein were replaced by foreign
ectodomain sequences. On the basis of the hydropho-
bicity profiles of the two proteins (Fig. 1), and the conve-
nient presence of unique EcoRI and XbaI restriction sites
(Fig. 1), residues Glu-115 (GP5) and Leu-17 (M protein)
were selected as the sites where the upstream, foreign
ectodomain was fused to the transmembrane region and
cytoplasmic domain of the EAV protein. Details on the
composition of each of the chimeric proteins are listed in
Table 1. The EAV GP5 ectodomain (residues 1–114) was
eplaced with the ectodomains of the corresponding
roteins (GP5 or GP7) of the three other arteriviruses, as
ell as with the unrelated and much larger ectodomain
equences of the SinV E1 and VSV G surface glycopro-
eins. Each of these ectodomains contained its native
ignal sequence. Following the initial results with these
himeras (see below), two M protein chimeras were
ngineered in which the small EAV M ectodomain (res-
dues 1–16) was replaced by the corresponding se-
uences from the PRRSV and LDV M proteins.
with EAV. (B) Colocalization of EAV M (red) and the cellular protein
disulfide isomerase (green), a marker for the ER. EAV-infected BHK-21
cells were fixed at 8 h pi and processed for double IFA using a mouse
MAb directed against PDI and a rabbit antiserum against EAV M. See
A for further details. (C) Immunofluorescence analysis showing the
intracellular distribution of the EAV GP5 (green) and M (red) proteins at
the onset (6 h pi) and peak (8 h pi) of structural protein expression in
EAV-infected BHK-21 cells. Note that the early M protein signal, like the
GP5 signal, localizes to the Golgi complex (also see A), whereas theFIG. 2. Localization of the EAV GP5 and M proteins in cells infected
with wild-type EAV. (A) Colocalization of EAV GP5 (red) and the cellular
protein mannosidase II (green), a marker for the Golgi complex. BHK-21
cells were infected with EAV, fixed at 8 h pi, and processed for double
IFA using a mouse MAb directed against GP5, an anti-mannosidase II
rabbit antiserum. The differentially fluorescing images were recorded
from the same optical section by using a confocal microscope as
described before (van der Meer et al., 1998). The right panel shows aate M protein signal shows a mixture of ER and Golgi localization (see
anel A for further details).
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287CONSTRUCTION OF CHIMERIC ARTERIVIRUSESEAV/LDV and EAV/PRRSV GP5 chimeras retain their
infectivity for BHK-21 cells
Full-length RNA was transcribed in vitro from the con-
structs with chimeric GP5 genes (pA45.C1 to pA45.C5;
able 1) and was transfected into BHK-21 cells as de-
cribed previously (van Dinten et al., 1997). A first im-
ression of the replicative properties of the chimeric
iruses was obtained by IFA. Labeling with an antiserum
gainst one of the EAV nonstructural proteins (nsp3)
emonstrated that all five GP5 chimeras were replication
ompetent (data not shown; van Dinten et al., 1997; Tijms
t al., 2001). IFAs for various structural proteins (Fig. 3
nd data not shown) revealed the synthesis of structural
roteins from subgenomic mRNAs. The double IFA for
he EAV GP5 and M proteins (see above, Figs. 2C, 3A1,
and 3A2) could not be used for the chimeric viruses
since all available anti-GP5 mouse MAbs recognize
epitopes in the ectodomain of GP5, which was replaced
in each of these chimeric viruses. However, we were
able to monitor the intracellular localization of the chi-
meric GP5 proteins by using a rabbit antiserum directed
against the C-terminal part of EAV GP5 (GP5 ct; Fig. 3A3).
urthermore, we employed the specific Golgi localization
f the M protein at early time points (Figs. 2C and 3A2) to
ssess whether formation and transport of the GP5–M
eterodimer occurred. It should be noted that, due to the
lectroporation of cells in suspension, the onset of EAV
nfection is about 2 h delayed in transfected cells. Con-
equently, the images of infected cells at 6 h pi (Fig. 2C)
nd transfected cells at 8 h posttransfection (Fig. 3)
epresent comparable stages of the EAV life cycle.
The IFA studies described above revealed that the GP5
chimeras could be divided into two groups. For the chi-
meric viruses derived from pA45.C1 and pA45.C2, con-
T
Composition of the GP5 and M Proteins
Construct Chimeric protein GP5 ectodomain
pA45 n.a. wt EAV GP5
pA45.C1 GP5 LDV GP5 aa 1–64
pA45.C2 GP5 PRRSV GP5 aa 1–64
pA45.C3 GP5 SHFV GP7 aa 1–138
pA45.C4 GP5 SinV E1 aa 1–428
c
pA45.C5 GP5 VSV G aa 1–402
pA56 n.a. wt EAV GP5
pA56.C1 M wt EAV GP5
pA56.C2 M wt EAV GP5
pA456 n.a. wt EAV GP5
pA456.C1 GP5 and M LDV GP5 aa 1–64
pA456.C2 GP5 and M PRRSV GP5 aa 1–64
a The unique EcoRI restriction site in the EAV ORF5 sequence was
b The unique XbaI restriction site in the EAV ORF6 sequence was u
c An N-terminal methionine residue was added, since the E1 proteintaining the LDV and PRRSV GP5 ectodomains, respec-
tively, transport of both the chimeric GP5 and the wild-
ttype (wt) M protein to the Golgi complex was observed,
as illustrated for pA45.C1 in Figs. 3B2, 3B3, 3C1, and 3C2.
For pA45.C1, we could carry out an additional control
using a mouse MAb recognizing the ectodomain of LDV
GP5 (Fig. 3B1), which recognized the LDV part of the
pA45.C1 GP5. This experiment confirmed that this LDV/
AV chimeric GP5 was indeed transported to the Golgi
omplex.
For the second group of chimeric viruses, derived from
A45.C3 (SHFV GP7), pA45.C4 (SinV E2), and pA45.C5
VSV G), no indications for transport of either the M
rotein or the chimeric GP5 to the Golgi complex were
btained (Figs. 3D1, 3D2, 3E1, and 3E2; pA45.C5 data not
hown). Both proteins appeared to be largely or com-
letely retained in the ER. In addition, a prominent and
nusual staining of the nuclear envelope could be ob-
erved for the M protein (Figs. 3D1 and 3E1), which is not
bserved under normal conditions (Fig. 3A2).
Subsequently, the production of infectious progeny
irus by cells transfected with the chimeric viruses was
nalyzed. For the viruses from the second group
pA45.C3, pA45.C4, and pA45.C5), spread of the infection
o untransfected cells in the culture, which was moni-
ored by IFA up to 72 h pi, was not detected. This was
ost likely explained by the fact that transport of both
P5 and the M protein of these viruses was blocked. For
the first two chimeras (pA45.C1 and pA45.C2), however,
efficient spread of the infection in the cell culture was
indeed observed, followed by cytopathogenic effect and
cell death at 40 to 48 h posttransfection. This suggested
that infectious chimeric virus particles (LDV/EAV and
PRRSV/EAV) were produced and, moreover, that particles
lacking the wt EAV GP5 ectodomain retained their infec-
ivity for BHK-21 cells. This was a surprising result since
eric and Nonchimeric EAV Constructs
Fused toa M ectodomain Fused tob
n.a. wt EAV M n.a.
P5 aa 115–255 wt EAV M n.a.
P5 aa 115–255 wt EAV M n.a.
P5 aa 115–255 wt EAV M n.a.
P5 aa 115–255 wt EAV M n.a.
P5 aa 115–255 wt EAV M n.a.
n.a. wt EAV M n.a.
n.a. LDV M aa 1–14 EAV M aa 17–162
n.a. PRRSV M aa 1–16 EAV M aa 17–162
n.a. wt EAV M n.a.
P5 aa 115–255 LDV M aa 1–14 EAV M aa 17–162
P5 aa 115–255 PRRSV M aa 1–16 EAV M aa 17–162
fuse the two parts of the chimeric gene.
fuse the two parts of the chimeric gene.
mally cleaved from the SinV structural polyprotein.ABLE 1
of Chim
EAV G
EAV G
EAV G
EAV G
EAV G
EAV G
EAV G
used tohe GP5 ectodomain was presumed to be involved in the
cell culture tropism of EAV and neither LDV nor PRRSV
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288 DOBBE ET AL.can infect BHK-21 cells. Thus, this result suggested that
the GP5 ectodomain is not the main determinant of EAV
ropism in cell culture.
haracterization of GP5 chimeras
To confirm the production of progeny virus by chime-
FIG. 3. Localization of the GP5 and M proteins in cells transfecte
posttransfection, a time point that matches the 6-h time point of infect
double labeled (A1/A2 and B1/B2) with various antibodies recognizin
ytoplasmic C-terminal domain of GP5 (panels labeled GP5 ct), or the
roteins of the wt control (pA45), showing the typical Golgi localization
ocalization of the hybrid LDV-EAV GP5 (B1/B3) and the M protein (B2) o
n antibody recognizing the LDV-derived ectodomain (B1) and using an
proteins of this viable chimera were both transported to the Golgi
PRRSV-EAV GP5 chimera (pA45.C2), again showing transport of both pr
onviable SHFV GP7-EAV GP5 chimera (pA45.C3). Neither the M prote
of the nuclear envelope was observed with the anti-M antiserum (D1).
chimera (pA45.C4), which both appeared to be retained in the ER.as pA45.C1 and pA45.C2, the medium of BHK-21 cul-
ures infected with each of the GP5 chimeras was har-
n
pested at 48 h posttransfection, cleared by low-speed
entrifugation, and used to infect a fresh dish of BHK-21
ells. After 24 h, cells were tested for infection by IFA.
nly the medium from the transfections with wt pA45,
A45.C1, and pA45.C2 contained virions that could infect
HK-21 cells. Subsequently, virus titers for pA45.C1 (data
different GP5 chimeras (see also Table 1). Cells were fixed at 8 h
eriments (see text and Fig. 2). Cells were labeled (A3, B3, C1–E2) or
ctodomain of GP5, (panels labeled GP5 ecto and LDV GP5 ecto), the
in (panels labeled M). (A) Localization of the GP5 (A1/A3) and M (A2)
and the mixed ER/Golgi staining observed for M (see also Fig. 2). (B)
V-EAV chimera (pA45.C1). The GP5 labeling was performed both using
rum recognizing the EAV-derived C-terminal domain (B3). The GP5 and
ex. (C) Localization of the M (C1) protein and GP5 (C2) of the viable
to the Golgi complex. (D) Localization of the GP5 and M proteins of the
P5 was transported to the Golgi complex and a pronounced staining
alization of the GP5 and M proteins of the nonviable SinV E1-EAV GP5d with
ion exp
g the e
M prote
of GP5
f the LD
antise
compl
oteins
in nor Got shown) and pA45.C2 (Fig. 4) were determined in a
laque assay. Titers of the wt virus were typically on the
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289CONSTRUCTION OF CHIMERIC ARTERIVIRUSESorder of 108 PFU/ml, whereas the pA45.C1- and pA45.C2-
erived viruses yielded titers that were 50- to 100-fold
ower. Furthermore, plaques derived from the latter two
iruses were at least 10 times smaller than those of the
t control virus (Fig. 4).
The virus with the chimeric EAV/PRRSV GP5 protein
(derived from pA45.C2) was selected for further charac-
terization. BHK-21 cells were infected with this chimera
or with the wt control at an m.o.i. of 3. By using IFAs, cells
were examined for nonstructural and structural protein
synthesis at various time points after infection. This com-
parison revealed that the general course of infection, as
measured by the onset of nonstructural and structural
protein synthesis, was comparable for both viruses. The
medium was harvested at 2-h intervals between 9 and
19 h pi and was subsequently titered using plaque as-
says (Fig. 5). This experiment revealed that also the
release of maximum progeny titers coincided for both
viruses (between 13 and 15 h pi), although—as before—
the titers obtained for the chimeric virus were about
100-fold lower than those obtained for the wt control
virus.
Finally, the pA45.C2-derived virus was passaged in
BHK-21 cells 10 times, after which the chimeric ORF5
sequence was amplified by RT–PCR. Sequence analysis
of the complete ORF5 revealed that, during this passag-
ing experiment, the chimeric gene had remained identi-
cal to that of the original pA45.C2 construct.
Construction of EAV/LDV and EAV/PRRSV M
and GP5-M chimeras
The virological characterization of the EAV/LDV and
EAV/PRRSV GP5 chimeras indicated that both chimeric
iruses were attenuated, although they remained infec-
FIG. 4. Plaque assay of the virus harvest (48 h posttranfection) from
HK-21 cells transfected with the PRRSV-EAV GP5 chimera (pA45.C2) or
the wt control (pA45), illustrating the differences in virus titers and
plaque size.ious for BHK-21 cells. The growth properties of the
AV/PRRSV GP5 were comparable to those of the wtirus (Fig. 5), but it yielded reduced titers and smaller
laques (Fig. 4). In view of the important role of the
P5–M heterodimer, we considered it likely that the
A45.C1- and pA45.C2-derived chimeric viruses were
ttenuated at the level of virion assembly or maturation,
esulting in lower titers and/or lower infectivity of the
rogeny virus.
In an attempt to improve the properties of the EAV/LDV
nd EAV/PRRSV GP5 chimeras, we engineered genes
ncoding corresponding chimeric M proteins, in which
he small ectodomain of the EAV M protein was replaced
y the corresponding domain of either the LDV or the
RRSV M protein (Table 1). The properties of the chi-
eric M proteins were tested independently (constructs
A56.C1 and pA56.C2) or in combination with the homol-
gous chimeric GP5 (constructs pA456.C1 and
A456.C2). Unfortunately, plaque assays and infection
xperiments with the medium from transfections with
hese constructs revealed that none of these novel chi-
eric viruses yielded progeny that was infectious for
HK-21 cells (data not shown). Transfected cells were
nalyzed by IFA and all four constructs were found to be
eplication- and transcription-competent, as deduced
rom the synthesis of both nonstructural and structural
roteins. However, transport of either the chimeric M
rotein or the chimeric GP5 to the Golgi complex was not
bserved (data not shown), suggesting that the het-
rodimerization of the two proteins was blocked.
DISCUSSION
The development of reverse genetics systems for ar-
eriviruses (van Dinten et al., 1997; Meulenberg et al.,
998; de Vries et al., 2000) has opened the possibility of
ngineering arterivirus genomes and particles with novel
roperties. As for other virus groups, such modified vi-
uses may be useful tools for exploring the antigenic
roperties of virus particles, virus–receptor interactions,
FIG. 5. Growth curve of the PRRSV-EAV GP5 chimera (pA45.C2;
harvest from the transfection experiment described in Fig. 4) and the wt
control. BHK-21 cells were infected with an m.o.i. of 3 and virus was
harvested at 2-h intervals from 9 to 19 h pi. Virus titers were determined
by plaque assays.
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290 DOBBE ET AL.or the development of novel vaccines and vectors. In the
case of arteriviruses, little is known about the require-
ments for virion assembly and infectivity. The 39-proximal
region of the EAV genome encodes seven proteins (E-
GP2b-GP3-GP4-GP5-M-N) and we have recently shown
hat each of these polypeptides is required to produce
nfectious EAV particles (Molenkamp et al., 2000). The
ollective evidence obtained for different arteriviruses
ndicates that at least six of these proteins are present in
he virion, with GP3 being the possible exception. How
hese proteins, and in particular the five or six putative
nvelope proteins, interact during arterivirus assembly
nd release remains an open question.
We have started our analysis of arterivirus assembly
y focusing on the only well-documented interaction
etween two arterivirus structural proteins, the formation
f a disulfide-bonded heterodimer between the major
nvelope proteins M and GP5. For EAV, a recent site-
directed mutagenesis study of the cysteine residues in
the ectodomains of these two proteins has revealed that
the interacting amino acids are Cys-8 of the M protein
and Cys-34 of GP5 (Fig. 6; E. J. Snijder, J. C. Dobbe, and
W. J. M. Spaan, manuscript in preparation). These studies
have confirmed that this interaction is indeed crucial for
the formation and transport of the GP5–M heterodimer,
without which virus assembly seems to be impossible.
In the present study, we have chosen to replace the
entire EAV GP5 ectodomain with both related and unre-
lated ectodomain sequences, each containing the origi-
nal N-terminal signal sequence. Two large and unrelated
ectodomains (those of VSV G and SinV E1) could not
substitute for the EAV GP5 ectodomain. Somewhat more
urprising was the fact that the chimeric protein contain-
ng the related GP7 ectodomain of the arterivirus SHFV,
FIG. 6. Sequence comparison of the ectodomains of wt and chimeric
r PRRSV IAF-Klop) sequences present in the hybrid proteins are depict
Signal sequences for the three GP5 proteins were predicted using the
residue downstream of the predicted signal sequence to the site (Gl
transmembrane region (TM). Potential N-glycosylation sites are underli
the M protein is boxed (E. J. Snijder, J. C. Dobbe, and W. J. M. Spaan
cysteine residue presumably involved in heterodimerization with GP5hich is only slightly larger than that of EAV, was also not
unctional. However, compared to the ectodomains of theajor glycoprotein of the other three arteriviruses, the
HFV GP7 ectodomain appears to be much more com-
plex in terms of the number of cysteine residues (seven)
and potential N-linked glysosylation sites (also seven).
For the EAV GP5 ectodomain, we have recently estab-
lished that all five cysteine residues and the N-glycosyl-
ation site are important for GP5 functionality (E. J. Snijder,
J. C. Dobbe, and W. J. M. Spaan, manuscript in prepara-
tion). Consequently, the SHFV GP7-EAV GP5 hybrid may
ave been misfolded and/or unable to form a het-
rodimer with the M protein. In the case of the LDV and
RRSV chimeras, the ectodomain exchange resulted in
n approximately 50-aa size reduction of the GP5 ectodo-
main (Fig. 6). Nevertheless, these chimeric proteins were
functional, in terms of both heterodimerization with the M
protein and virus infectivity. Previously, EAV neutraliza-
tion escape mutants with 41- and 47-aa deletions in the
GP5 ectodomain have been described (Balasuriya et al.,
1997), indicating that the size of this part of the protein
can indeed be reduced without loss of function.
In a recent paper, de Vries et al. (2000) described the
N-terminal extension of the ectodomain of the EAV M
protein with a nonapeptide derived from the mouse coro-
navirus M protein, which carries the O-glycosylation sig-
nal of the latter (de Haan et al., 1998). An EAV chimera
carrying this hybrid M protein, which was indeed O-
glycosylated, was viable and genetically stable, although
virus titers were severely reduced. In our present study,
however, the M protein appeared to be much more sen-
sitive to N-terminal modification. Replacing the ectodo-
main (16 aa) of the EAV M protein with the corresponding
sequences of LDV (14 aa) or PRRSV (16 aa) apparently
blocked M protein function despite the fact that size,
charge, and the central position of a cysteine residue
d M proteins. The wt EAV-Bucyrus ectodomains and the foreign (LDV-P
ray and white boxes, respectively. (A) Comparison of GP5 ectodomains.
d of Nielsen et al. (1997). Depicted are the sequences from the first
Phe116) at which the foreign sequences were fused to the EAV GP5
e cysteine residue presumed to be involved in heterodimerization with
cript in preparation). (B) Comparison of M protein ectodomains. The
d.GP5 an
ed in g
metho
u-115,
ned. Thwere maintained in the chimeric proteins (Fig. 6). Com-
bining these chimeric proteins with the corresponding
br
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291CONSTRUCTION OF CHIMERIC ARTERIVIRUSESchimeric GP5 proteins did not improve the interaction
etween the GP5 and M proteins, since the two proteins
were not transported to the Golgi complex and the pro-
duction of infectious progeny virus was completely
blocked.
The two viable chimeras produced small plaques (Fig.
4) and their titers were about 50-fold reduced compared
to that of the wt EAV construct, an observation that is not
unusual for chimeric viruses. This attenuation may sim-
ply reflect a decrease in virus production, e.g., due to the
suboptimal properties of the chimeric GP5. However,
passaging of the PRRSV-EAV GP5 chimera did not result
in adaptive mutations in the GP5 ectodomain or in in-
creased virus titers. Alternatively, the specific infectivity
or stability of the chimeric progeny virions may be af-
fected. Although the binding of the chimeras to BHK-21
cells remains to be analyzed in detail, the comparative
infection experiment with the PRRSV-EAV chimera and wt
virus (Fig. 5) suggested that these viruses were equally
able to enter BHK-21 cells, initiate an infection, and
release their maximum progeny titers after approxi-
mately 13 h.
In our opinion, the most surprising result of this study
was the finding that chimeric viruses containing the LDV
or PRRSV GP5 ectodomains remained infectious for the
baby hamster kidney cells (BHK-21) in which they had
been generated. Also rabbit kidney cells (RK-13) could be
infected by both chimeric viruses (data not shown). Both
BHK-21 and RK-13 cells can be infected by EAV, but not
by either LDV or PRRSV. The relatively broad tropism of
EAV in cell culture (see Introduction) is exceptional
among arteriviruses. As for many other viruses, including
the related coronaviruses (Kuo et al., 2000), the ectodo-
main of the major glycoprotein was expected to be an
important determinant of tropism in the case of EAV, in
particular because it also carries the only known neu-
tralization determinants (Balasuriya et al., 1997; Chirn-
side et al., 1995; Deregt et al., 1994; Glaser et al., 1995).
We established that the EAV GP5 ectodomain can be
eplaced by two sequences that are only distantly related
Fig. 6) and much smaller. This could imply that this part
f the EAV major glycoprotein is not required at all for
eceptor binding or virus entry. In that case, one of the
ther, poorly characterized arterivirus surface proteins,
ike GP2b or GP4, may be essential for these processes.
lternatively, the GP5 ectodomain may be involved in cell
binding, with a second protein determining the host cell
specificity. In view of the intimate relationship between
the arterivirus GP5 and M proteins, the triple-spanning M
rotein is an interesting candidate for such a role. Re-
ently, Balasuriya et al. (2000) reported that the simulta-
neous expression of both GP5 and M is required for the
induction of neutralizing antibodies in mice. Neverthe-
less, neutralizing antibodies against EAV in horses can
be induced using peptides derived from the GP5 ectodo-
ain (Chirnside et al., 1995). Since expression of PRRSVGP5 was also reported to induce neutralizing immunity in
igs (Pirzadeh et al., 1998), it will be interesting to deter-
ine the immunogenic properties of the PRRSV/EAV and
DV/EAV chimeras in pigs and mice, respectively.
MATERIALS AND METHODS
ells, virus, and antisera
Baby hamster kidney (BHK-21) were used for infection
xperiments with the EAV Bucyrus strain (Doll et al.,
957) or viruses produced from (derivatives of) an EAV
nfectious cDNA clone (van Dinten et al., 1997) following
the protocol described by de Vries et al. (1992). The EAV
nsp3-specific rabbit antiserum was described previously
(Pedersen et al., 1999). Rabbit antisera SP06 (de Vries et
al., 1992) and FP55, recognizing the C-terminal regions of
the EAV M and GP5 proteins, were obtained from Dr.
A. A. F. de Vries and Dr. P. J. M. Rottier (Utrecht Univer-
sity). Mouse monoclonal antibodies (MAbs) 93B (Glaser
et al., 1995) and 6D10 (Balasuriya et al., 1997) against
EAV GP5 were kindly provided by Dr. A. L. Glaser (Cornell
University) and Dr. U. Balasuriya and Dr. N. J. Mac-
Lachlan (University of California), respectively. Neutraliz-
ing MAb 159.18 recognizing LDV GP5 (Harty and Plage-
ann, 1988) was obtained from Dr. P. G. W. Plagemann
University of Minnesota). A rabbit antiserum against the
ellular Golgi protein mannosidase II (Moremen and
ouster, 1985) was provided by Dr. K. W. Moremen (Uni-
ersity of Georgia). Monoclonal antibody 1D3 against
rotein disulfide isomerase (Vaux et al., 1990) was a gift
rom Dr. S. Fuller (EMBL Heidelberg).
onstruction of chimeric full-length cDNA clones
EAV infectious cDNA clone pEAV030 (van Dinten et al.,
997) was the backbone for all chimeric constructs used
n this study. Constructs in which the overlaps between
AV ORFs 4 and 5 (pEAV030-BglIIKO-4/5) and between
AV ORFs 5 and 6 (pBRNX1.38-5/6) have been removed
de Vries et al., 2000) were kindly provided by Dr. A. A. F.
e Vries, Dr. A. L. Glaser, and Dr. P. J. M. Rottier (Utrecht
niversity). Restriction fragments containing the mutated
egions (BglII–EcoRI, corresponding to nt 10,704–11,488
f the EAV genome, and EcoRI–XbaI, nt 11,488–11,948)
ere transferred to pEAV030 to create constructs pA45
ORFs 4 and 5 separated), pA56 (ORFs 5 and 6 sepa-
ated), and pA456 (ORFs 4 , 5, and 6 separated), in which
he sequences encoding the ectodomains of the GP5
and/or M proteins could be replaced without affecting
the coding sequence of any of the other EAV proteins
(Fig. 1A).
Subsequently, we engineered five constructs with a
chimeric GP5 (pA45.C1 to pA45.C5), two constructs with
a chimeric M protein (pA56.C1 and pA56.C2), and two
constructs with a combination of chimeric GP5 and M
proteins (pA456.C1 and pA456.C2) (Table 2). In these
(
t
p
X
t
w
l
v
d
.
292 DOBBE ET AL.chimeras the ectodomains of the EAV GP5 and/or M
proteins were replaced by ectodomain sequences of
LDV GP5 and/or M (C1 constructs), PRRSV GP5, and/or M
(C2 constructs), SHFV GP7 (construct pA45.C3), SinV E2
construct pA45.C4), and VSV G (construct pA45.C5). To
his end, we replaced either the AflII–EcoRI fragment of
A45, containing the ORF4–ORF5 junction, or the AflII–
baI fragment of pA56, containing the ORF5–ORF6 junc-
ion, or both fragments of construct pA456. The inserts
ere generated in PCR reactions using the primers
isted in Table 2 and cloned cDNA sequences of the
arious donor viruses as template. PCR products were
igested with either AflII and EcoRI (GP5 ectodomain
chimeras) or with AflII and XbaI (M ectodomain chime-
ras) and inserted into pA45 or pA56, respectively. Follow-
ing ligation and transformation, the PCR-derived inserts
of all constructs were sequenced completely. The pA456
C1 and C2 double chimeras were engineered by com-
bining the mutations of the corresponding pA45 and
pA56 single chimeric constructs. The inserted se-
quences were derived from the following virus strains:
LDV P (GenBank Database Accession No. U15146;
Palmer et al., 1995), PRRSV IAF-Klop (Accession No.
U64928; Pirzadeh et al., 1998), SHFV LVR 42-0/M6941
(Accession No. U63121; Smith et al., 1997), VSV Indiana
serotype San Juan strain (Accession No. NC001560;
Rose and Gallione, 1981), and SinV HR (Accession No.
NC001547; Strauss et al., 1984) were used as templates.
Infection and transfection experiments
Infection experiments with EAV were performed in
BHK-21 cells according to de Vries et al. (1992). BHK-21
cells were also used for transfection experiments with in
vitro generated transcripts from the EAV infectious cDNA
T
PCR Primers Used to Generate Foreign Inserts for
Primer Sequence (59 3 39)a
LDV050 CCCAAGCTTGCGGCCGCATCATGAAATGTT
LDV051 AGGAATTCTACCGCGTAACCG
LDV052 CCCAAGCTTGCGGCCGCATCATGGGAGGCC
LDV053 GTAATCTAGATACCAGGAAGTTTG
PRRSV001 CCCAAGCTTGCGGCCGCAGCATGCTGGGGA
PRRSV002 AGGAATTCCACTGCCCAATCAAA
PRRSV004 CCCAAGCTTGCGGCCGCATCATGGTGTCGT
PRRSV005 GTAATCTAGAGGGGCCGTGCTGTC
SHFV001 CCCAAGCTTGCGGCCGCATCATGTACTTAT
SHFV002 AGGAATTCATTGATGTGGTGTCCAG
S226 CCCAAGCTTGCGGCCGCATCATGAGCGCAG
S227 AGGAATTCAGGATGGCGATGGTAG
VSV001 CCCAAGCTTGCGGCCGCATCATGAAGTGCC
VSV002 AGGAATTCTTTCCAACTACTGAACCAACC
a Restriction sites used for cloning of PCR fragments are underlinedclone pEAV030 and derivatives thereof using the previ-
ously described electroporation protocol (van Dinten etal., 1997). For plaque assays, subconfluent monolayers of
BHK-21 cells were infected with 10-fold serial dilutions of
wt or recombinant EAV. Following a 1-h incubation, a 1%
agarose overlay was applied and cells were incubated at
39.5°C. Plaques were visible between 2 and 5 days after
infection, depending on the (recombinant) virus being
analyzed.
Immunofluorescence microscopy
The preparation of cells IFAs was essentially as de-
scribed by van der Meer et al. (1998). As secondary
antibodies, a Cy3-conjugated donkey anti-rabbit IgG an-
tibody and a fluorescein isothiocyanate (FITC)-conju-
gated goat anti-mouse IgG antibody (both from Jackson
ImmunoResearch Laboratories) were used. For conven-
tional fluorescence microscopy, samples were examined
using an Olympus microscope equipped with a digital
camera and Qfluoro software (Leica). Confocal fluores-
cence microscopy was performed with the confocal
scanning laser beam microscope (CCM) developed at
the European Molecular Biology Laboratory, Heidelberg,
Germany, as described previously (van der Meer et al.,
1998).
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nstruction of Chimeric GP5 and M Protein Genes
Polarity Chimeric protein
AAATTG 1 LDV/EAV GP5
2 LDV/EAV GP5
1 LDV/EAV M
2 LDV/EAV M
TTGAC 1 PRRSV/EAV GP5
2 PRRSV/EAV GP5
GACG 1 PRRSV/EAV M
2 PRRSV/EAV M
GG 1 SHFV/EAV GP5
2 SHFV/EAV GP5
CTGGTC 1 SinV E1/EAV GP5
2 SinV E1/EAV GP5
1 VSV G/EAV GP5
2 VSV G/EAV GP5ABLE 2
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